All In MedTech

Device Trial Radar · NCT04502316

Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry)

Real-World Experience -- Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry) A Post-Market Registry With the Barostim™ System

Last checked: Nov 19, 2026Latest source record: Sep 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

435

Actual

Start

Jun 26, 2020

Primary completion

May 14, 2026

Study completion Jun 30, 2026

Sponsor

Lead sponsor
CVRx, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Aug 6, 2020

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this registry is to develop valid scientific evidence of the safety and benefit of Barostim Therapy in the commercial setting in patients with heart failure with reduced ejection fraction (HFrEF) that were recently implanted with the Barostim System.

Conditions

  • Heart Failure

Interventions

  • Barostim™ SystemDevice

    Implantation of the Barostim™ System

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The primary objective of this post-market registry is to develop valid scientific evidence of the safety and benefit of Barostim Therapy in the commercial setting in patients that were recently implanted with the Barostim System.Time frame: 36 months post-implant

Locations

46 sites in 1 country. Site status is shown where the registry gives one.

  • Grandview Medical Center

    Birmingham, Alabama

  • Chan Heart Rhythm Institute

    Mesa, Arizona

  • Akil Loli Consulting LLC

    Phoenix, Arizona

43 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.